Curaleaf Holdings (CURLF) Work In Process (2019 - 2022)
Curaleaf Holdings (CURLF) posted quarterly Work In Process of $119.0 million for Q4 2022, up 30.76% year-on-year from $91.0 million in Q4 2021, and up 30.76% on a QoQ basis from $91.0 million in Q4 2021.
Curaleaf Holdings (CURLF) Work In Process (2019 - 2022) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Work In Process for 4 consecutive years, with $119.0 million the latest figure, recorded in Q4 2022.
- Quarterly Work In Process rose 30.76% year-over-year to $119.0 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $119.0 million (up 30.76% YoY) and the FY2021 annual result came in at $91.0 million, up 29.01% from the prior year.
- Work In Process rose to $119.0 million in Q4 2022 per CURLF's latest filing, from $91.0 million in the prior quarter.
- Over the last five years, Work In Process for CURLF reached as high as $119.0 million in Q4 2022 and fell as low as $16.0 million in Q4 2019.
- A 4-year average of $74.1 million and a median of $80.8 million in 2020 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2020 — Work In Process surged 340.93% — and 2021, when it grew 29.01%.
- Year by year, Work In Process stood at $16.0 million in 2019, then soared by 340.93% to $70.5 million in 2020, then climbed by 29.01% to $91.0 million in 2021, then surged by 30.76% to $119.0 million in 2022.
- According to Business Quant data, Work In Process over the past three periods registered $119.0 million, $91.0 million, and $70.5 million for Q4 2022, Q4 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 119.00 Mn |
| Dec 31, 2021 | 91.00 Mn |
| Dec 31, 2020 | 70.54 Mn |
| Dec 31, 2019 | 16.00 Mn |